Company intelligence / Profile preview

Bordoloi Biotech

New Delhi, Delhi, Indiabordoloibiotech.com ↗

Ownership: Private
Development stage: Other

Overview

Bordoloi Biotech develops proprietary chemical and material solutions targeting unmet needs in inflammation/pain management and tissue engineering/hemostasis. The company holds granted US patents and seeks both commercial development partners and licensees. No published clinical trial results or approved products are listed publicly as of now.

Therapeutic areas: ImmunologyNeurologyHematology
Modalities: Small molecules (chemistry solutions for biological systems)Medical devices/materials for tissue engineering and hemostasis
Industry: Biotech

Drug pipeline

1 asset

HerboCare

Unknown

Partnerships

Seeking licensing/commercialization partners; no major pharma/biotech partnerships disclosed publicly as of May 2025.

Beyond the preview

Go deeper on Bordoloi Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bordoloi Biotech.

Explore the full profile